Lars Helldin

Summary

Country: Sweden

Publications

  1. ncbi request reprint Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia
    Ola Gefvert
    Centre for Clinical Research, University of Uppsala, Central Hospital Västerås, Sweden
    Int J Neuropsychopharmacol 8:27-36. 2005
  2. ncbi request reprint Remission and cognitive ability in a cohort of patients with schizophrenia
    Lars Helldin
    Department of Psychiatry, NU Health Care, SE 461 85 Trollhättan, Sweden
    J Psychiatr Res 40:738-45. 2006
  3. doi request reprint A functional comparison of patients with schizophrenia between the North and South of Europe
    L Helldin
    Department of Psychiatry, NU Health Care Hospital, 46185 Trollhattan, Sweden
    Eur Psychiatry 27:442-4. 2012
  4. doi request reprint Psychometric properties of a performance-based measurement of functional capacity, the UCSD Performance-based Skills Assessment - Brief version
    Anna Karin Olsson
    NU Health Care, Department of Psychiatry, Trollhattan, Sweden
    Psychiatry Res 197:290-4. 2012
  5. doi request reprint Illness-related components for the family burden of relatives to patients with psychotic illness
    Fredrik Hjärthag
    Department of Psychiatry, NU Healthcare, 461 85 Trollhättan, Sweden
    Soc Psychiatry Psychiatr Epidemiol 45:275-83. 2010
  6. doi request reprint The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study
    Lars Helldin
    The NU Health Care, Department of Psychiatry, Trollhattan, Sweden
    Schizophr Res 115:67-73. 2009
  7. ncbi request reprint Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders
    Lars Helldin
    The NU Health Care, Department of Psychiatry, SE 461 85 Trollhättan, Sweden
    Schizophr Res 93:160-8. 2007
  8. doi request reprint Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study
    Lars Helldin
    Department of Psychiatry, NU Health Care, Trollhattan, Sweden Department of Psychology, Karlstad University, Karlstad, Sweden Electronic address
    Schizophr Res 169:141-6. 2015
  9. doi request reprint Predicting real-world functional milestones in schizophrenia
    Anna Karin Olsson
    Department of Psychiatry, NU Health Care, Trollhattan, Sweden Department of Psychology, Karlstad University, Karlstad, Sweden Electronic address
    Psychiatry Res 242:1-6. 2016
  10. ncbi request reprint Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels
    Ulla Karilampi
    Department of Psychology, University of Gothenburg, Box 500, S 405 30 Gothenburg, Sweden
    Arch Clin Neuropsychol 22:161-74. 2007

Detail Information

Publications11

  1. ncbi request reprint Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia
    Ola Gefvert
    Centre for Clinical Research, University of Uppsala, Central Hospital Västerås, Sweden
    Int J Neuropsychopharmacol 8:27-36. 2005
    ..1 and 22.5-26.3 ng/ml respectively. The results indicate that brain D2 receptor occupancy at steady state after injections of long-acting risperidone was in the range found in patients effectively treated with 2-6 mg of oral risperidone...
  2. ncbi request reprint Remission and cognitive ability in a cohort of patients with schizophrenia
    Lars Helldin
    Department of Psychiatry, NU Health Care, SE 461 85 Trollhättan, Sweden
    J Psychiatr Res 40:738-45. 2006
    ..The importance of cognitive performance was studied to decide whether cognitive ability is a contributing factor for achieving remission...
  3. doi request reprint A functional comparison of patients with schizophrenia between the North and South of Europe
    L Helldin
    Department of Psychiatry, NU Health Care Hospital, 46185 Trollhattan, Sweden
    Eur Psychiatry 27:442-4. 2012
    ..Also, to study if outcome is to be regarded as a consequence of premorbid function, the level of symptom control and functional capacity or if other influences, such as cultural differences, must parallel be considered...
  4. doi request reprint Psychometric properties of a performance-based measurement of functional capacity, the UCSD Performance-based Skills Assessment - Brief version
    Anna Karin Olsson
    NU Health Care, Department of Psychiatry, Trollhattan, Sweden
    Psychiatry Res 197:290-4. 2012
    ..The conclusion drawn is that the UPSA-B is a valuable instrument that could be used in future cross-national studies to describe the level of functioning for patients with schizophrenia and other psychotic illnesses...
  5. doi request reprint Illness-related components for the family burden of relatives to patients with psychotic illness
    Fredrik Hjärthag
    Department of Psychiatry, NU Healthcare, 461 85 Trollhättan, Sweden
    Soc Psychiatry Psychiatr Epidemiol 45:275-83. 2010
    ..This study investigates how family burden is affected by symptom, function, and cognition, as well as how the patient perceives his/her illness and quality of life...
  6. doi request reprint The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study
    Lars Helldin
    The NU Health Care, Department of Psychiatry, Trollhattan, Sweden
    Schizophr Res 115:67-73. 2009
    ..This study examines the relationship between having achieved cross-sectional remission and the need for future psychiatric and nursing home care. The study is a prospective long-term follow-up of patients with schizophrenia...
  7. ncbi request reprint Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders
    Lars Helldin
    The NU Health Care, Department of Psychiatry, SE 461 85 Trollhättan, Sweden
    Schizophr Res 93:160-8. 2007
    ..The hypothesis was that patients having attained remission would function at a higher level and have a lower care requirement than those who had not attained remission...
  8. doi request reprint Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study
    Lars Helldin
    Department of Psychiatry, NU Health Care, Trollhattan, Sweden Department of Psychology, Karlstad University, Karlstad, Sweden Electronic address
    Schizophr Res 169:141-6. 2015
    ..Our findings indicate that cognitive abilities might be of special interest for affective longevity in patients with schizophrenia, either as a marker of special risk or as a target for direct intervention...
  9. doi request reprint Predicting real-world functional milestones in schizophrenia
    Anna Karin Olsson
    Department of Psychiatry, NU Health Care, Trollhattan, Sweden Department of Psychology, Karlstad University, Karlstad, Sweden Electronic address
    Psychiatry Res 242:1-6. 2016
    ..We also conclude that there is an advantage in exploring symptoms divided into positive, negative, and general domains considering their probable impact on functional achievements. ..
  10. ncbi request reprint Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels
    Ulla Karilampi
    Department of Psychology, University of Gothenburg, Box 500, S 405 30 Gothenburg, Sweden
    Arch Clin Neuropsychol 22:161-74. 2007
    ..The aim was to analyze and compare neurocognitive test profiles related to different levels of verbal learning performance among schizopsychotic patients and healthy volunteers...
  11. ncbi request reprint Remission in schizophrenia: applying recent consensus criteria to refine the concept
    Robert A Lasser
    Neuliance, 12 Penns Trail, Suite 113 Newtown, PA 18940, USA
    Schizophr Res 96:223-31. 2007
    ....